These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 23817808)
1. EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas. Tsai WC; Chen Y; Huang LC; Lee HS; Ma HI; Huang SM; Sytwu HK; Hueng DY J Neurooncol; 2013 Sep; 114(3):281-90. PubMed ID: 23817808 [TBL] [Abstract][Full Text] [Related]
2. ARID4B is a good biomarker to predict tumour behaviour and decide WHO grades in gliomas and meningiomas. Tsai WC; Hueng DY; Nieh S; Gao HW J Clin Pathol; 2017 Feb; 70(2):162-167. PubMed ID: 27451434 [TBL] [Abstract][Full Text] [Related]
3. EMMPRIN is an independent negative prognostic factor for patients with astrocytic glioma. Tian L; Zhang Y; Chen Y; Cai M; Dong H; Xiong L PLoS One; 2013; 8(3):e58069. PubMed ID: 23516431 [TBL] [Abstract][Full Text] [Related]
4. Nrf2 Expressions Correlate with WHO Grades in Gliomas and Meningiomas. Tsai WC; Hueng DY; Lin CR; Yang TC; Gao HW Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187376 [TBL] [Abstract][Full Text] [Related]
5. Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival. Ke HL; Ke RH; Li B; Wang XH; Wang YN; Wang XQ Acta Neurochir (Wien); 2013 Jan; 155(1):165-71. PubMed ID: 23053286 [TBL] [Abstract][Full Text] [Related]
6. Clinical implications and prognostic value of EMMPRIN/CD147 and MMP2 expression in pediatric gliomas. Gu J; Zhang C; Chen R; Pan J; Wang Y; Ming M; Gui W; Wang D Eur J Pediatr; 2009 Jun; 168(6):705-10. PubMed ID: 18795327 [TBL] [Abstract][Full Text] [Related]
7. Impact of MACC1 on human malignant glioma progression and patients' unfavorable prognosis. Hagemann C; Fuchs S; Monoranu CM; Herrmann P; Smith J; Hohmann T; Grabiec U; Kessler AF; Dehghani F; Löhr M; Ernestus RI; Vince GH; Stein U Neuro Oncol; 2013 Dec; 15(12):1696-709. PubMed ID: 24220141 [TBL] [Abstract][Full Text] [Related]
8. Expression of RACGAP1 in high grade meningiomas: a potential role in cancer progression. Ke HL; Ke RH; Li ST; Li B; Lu HT; Wang XQ J Neurooncol; 2013 Jun; 113(2):327-32. PubMed ID: 23525949 [TBL] [Abstract][Full Text] [Related]
9. Expression of emmprin (CD147), a cell surface inducer of matrix metalloproteinases, in normal human brain and gliomas. Sameshima T; Nabeshima K; Toole BP; Yokogami K; Okada Y; Goya T; Koono M; Wakisaka S Int J Cancer; 2000 Oct; 88(1):21-7. PubMed ID: 10962435 [TBL] [Abstract][Full Text] [Related]
10. Expression of matrix metalloproteinases and their inhibitors in human brain tumors. Kachra Z; Beaulieu E; Delbecchi L; Mousseau N; Berthelet F; Moumdjian R; Del Maestro R; Béliveau R Clin Exp Metastasis; 1999; 17(7):555-66. PubMed ID: 10845554 [TBL] [Abstract][Full Text] [Related]
11. High CHI3L1 expression is associated with glioma patient survival. Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858 [TBL] [Abstract][Full Text] [Related]
12. DDX3X Biomarker Correlates with Poor Survival in Human Gliomas. Hueng DY; Tsai WC; Chiou HY; Feng SW; Lin C; Li YF; Huang LC; Lin MH Int J Mol Sci; 2015 Jul; 16(7):15578-91. PubMed ID: 26184164 [TBL] [Abstract][Full Text] [Related]
13. The expression of hypoxia-inducible factor-1 in primary brain tumors. Reszec J; Rutkowski R; Chyczewski L Int J Neurosci; 2013 Sep; 123(9):657-62. PubMed ID: 23550771 [TBL] [Abstract][Full Text] [Related]
14. The association of osteopontin and LMX1A expression with World Health Organization grade in meningiomas and gliomas. Tsai WC; Lee HS; Lin CK; Chen A; Nieh S; Ma HI Histopathology; 2012 Nov; 61(5):844-56. PubMed ID: 22882568 [TBL] [Abstract][Full Text] [Related]
15. Dynamic susceptibility contrast and dynamic contrast-enhanced MRI characteristics to distinguish microcystic meningiomas from traditional Grade I meningiomas and high-grade gliomas. Hussain NS; Moisi MD; Keogh B; McCullough BJ; Rostad S; Newell D; Gwinn R; Foltz G; Mayberg M; Aguedan B; Good V; Fouke SJ J Neurosurg; 2017 Apr; 126(4):1220-1226. PubMed ID: 27285539 [TBL] [Abstract][Full Text] [Related]
16. Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma. Du Z; Abedalthagafi M; Aizer AA; McHenry AR; Sun HH; Bray MA; Viramontes O; Machaidze R; Brastianos PK; Reardon DA; Dunn IF; Freeman GJ; Ligon KL; Carpenter AE; Alexander BM; Agar NY; Rodig SJ; Bradshaw EM; Santagata S Oncotarget; 2015 Mar; 6(7):4704-16. PubMed ID: 25609200 [TBL] [Abstract][Full Text] [Related]
17. EMMPRIN promotes angiogenesis, proliferation, invasion and resistance to sunitinib in renal cell carcinoma, and its level predicts patient outcome. Sato M; Nakai Y; Nakata W; Yoshida T; Hatano K; Kawashima A; Fujita K; Uemura M; Takayama H; Nonomura N PLoS One; 2013; 8(9):e74313. PubMed ID: 24073208 [TBL] [Abstract][Full Text] [Related]
19. RRP22: a novel neural tumor suppressor for astrocytoma. Chen R; Yang L; Fang J; Huo L; Zhang M; Chen F; Liu J; Wu J; Wang Y Med Oncol; 2012 Mar; 29(1):332-9. PubMed ID: 21264544 [TBL] [Abstract][Full Text] [Related]
20. Highly expressed tumoral emmprin and stromal CD73 predict a poor prognosis for external auditory canal carcinoma. Miyazaki M; Aoki M; Okado Y; Koga K; Hamasaki M; Nakagawa T; Sakata T; Nabeshima K Cancer Sci; 2020 Aug; 111(8):3045-3056. PubMed ID: 32473077 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]